ORal IrON Supplementation With Ferric Maltol in Patients With Heart Failure Carrying Left Ventricular Assist Devices
Status:
Terminated
Trial end date:
2019-11-29
Target enrollment:
Participant gender:
Summary
This is a open-label, uncontrolled, monocenter, phase IV study. The aim of this study is to
detect AEs or SAEs with a relative frequency of at least 11.5% in LVAD patients with iron
deficiency anemia treated with oral ferric maltol for 12 weeks.